September 21, 2018 / 11:45 AM / 3 months ago

BRIEF-Novartis Wins Positive CHMP Opinion For Gilenya For MS In Children

Sept 21 (Reuters) - Novartis AG:

* NOVARTIS RECEIVES POSITIVE CHMP OPINION FOR GILENYA® FOR THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH MS, MARKING A MAJOR MEDICAL ADVANCE FOR YOUNG MS PATIENTS IN EUROPE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below